Discontinued — last reported Q2 '24
Medtronic AFS Securities increased by 7.0% to $3.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from $3.19B to $3.13B. Over 5 years (FY 2020 to FY 2025), AFS Securities shows a downward trend with a -2.5% CAGR.
An increase reflects capital allocation toward investment portfolios, while a decrease may signal portfolio rebalancing or asset liquidation.
Available-for-sale securities are debt or equity investments that are not classified as trading or held-to-maturity, and...
Common in the investment portfolios of banks and insurance companies.
fin_afs_securities| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.98B | $3.20B | $3.34B | $3.60B | $3.65B | $3.71B | $3.80B | $3.74B | $3.71B | $3.33B | $3.25B | $3.19B | $3.02B | $2.92B | $3.13B |
| QoQ Change | — | +7.4% | +4.3% | +7.8% | +1.4% | +1.6% | +2.5% | -1.6% | -0.8% | -10.3% | -2.3% | -1.9% | -5.3% | -3.1% | +7.0% |
| YoY Change | — | — | — | +20.8% | +14.1% | +11.1% | +5.6% | +2.4% | +0.0% | -12.5% | -13.1% | -14.1% | -9.3% | -10.1% | -1.9% |